We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ezcorp Inc
EZPW
$1.8B
| $5.51M | 0.04% |
676,194
+232,790
| +53% | +$2.08M |
|
377
Domo
DOMO
$176M
| $5.5M | 0.04% |
386,006
+87,433
| +29% | +$1.36M |
|
378
Trinity Industries
TRN
$3B
| $5.48M | 0.04% |
185,486
-345,881
| -65% | -$9.64M |
|
379
Sutro Biopharma
STRO
$387M
| $5.39M | 0.04% |
66,748
-7,575
| -10% | -$526K |
|
380
Amphastar Pharmaceuticals
AMPH
$902M
| $5.34M | 0.04% |
190,672
+2,633
| +1% | +$76.5K |
|
381
Chemours
CC
$2.48B
| $5.33M | 0.04% |
174,008
-2,289
| -1% | -$68.7K |
|
382
Customers Bancorp
CUBI
$2.67B
| $5.3M | 0.04% |
187,017
-3,064
| -2% | -$95.5K |
|
383
Scorpio Tankers
STNG
$3.91B
| $5.3M | 0.04% |
98,509
+63,748
| +183% | +$3.18M |
|
384
GoodRx Holdings
GDRX
$1.06B
| $5.29M | 0.04% |
1,134,610
-311,593
| -22% | -$1.54M |
|
385
UnitedHealth
UNH
$387B
| $5.27M | 0.04% |
9,945
+1,125
| +13% | +$596K |
|
|
HSII
386
DELISTED
Heidrick & Struggles
HSII
| $5.25M | 0.04% |
187,612
+3,765
| +2% | +$107K |
|
387
Quanex
NX
$839M
| $5.23M | 0.04% |
220,985
+5,838
| +3% | +$131K |
|
|
BLUE
388
DELISTED
bluebird bio
BLUE
| $5.23M | 0.04% |
37,757
+31,396
| +494% | +$4.42M |
|
389
TriNet
TNET
$3.28B
| $5.22M | 0.04% |
76,937
+2,666
| +4% | +$184K |
|
390
Argan
AGX
$7.03B
| $5.16M | 0.03% |
139,879
-2,752
| -2% | -$96.8K |
|
391
Eagle Bancorp
EGBN
$866M
| $5.14M | 0.03% |
116,592
-7,817
| -6% | -$353K |
|
|
CLDT
392
Chatham Lodging
CLDT
$633M
| $5.12M | 0.03% |
416,983
+101,602
| +32% | +$1.25M |
|
|
MCHB
393
Mechanics Bancorp
MCHB
$3.59B
| $5.1M | 0.03% |
185,006
+2,358
| +1% | +$64.5K |
|
|
DCH
394
Dauch Corp
DCH
$1.31B
| $5.1M | 0.03% |
652,142
-939,652
| -59% | -$8.42M |
|
395
Brown & Brown
BRO
$25.1B
| $5.09M | 0.03% |
89,319
-9,873
| -10% | -$577K |
|
|
ONTF
396
DELISTED
ON24
ONTF
| $5M | 0.03% |
579,753
-26,336
| -4% | -$211K |
|
397
Inogen
INGN
$175M
| $4.99M | 0.03% |
253,180
-1,505
| -0.6% | -$32.4K |
|
|
HT
398
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $4.95M | 0.03% |
581,538
+534,406
| +1,134% | +$4.79M |
|
|
REVG
399
DELISTED
REV Group
REVG
| $4.91M | 0.03% |
388,744
-23,862
| -6% | -$314K |
|
400
Willis Towers Watson
WTW
$30.1B
| $4.86M | 0.03% |
19,882
-23,661
| -54% | -$5.41M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.